Di Caro, Antonino
 Distribuzione geografica
Continente #
AS - Asia 1.210
NA - Nord America 972
SA - Sud America 493
EU - Europa 177
AF - Africa 58
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 2.913
Nazione #
US - Stati Uniti d'America 886
SG - Singapore 459
BR - Brasile 377
CN - Cina 228
HK - Hong Kong 166
VN - Vietnam 108
IT - Italia 78
MX - Messico 60
IN - India 40
BD - Bangladesh 35
AR - Argentina 33
IQ - Iraq 27
PK - Pakistan 24
CO - Colombia 23
EC - Ecuador 21
ID - Indonesia 21
TR - Turchia 21
GB - Regno Unito 19
DE - Germania 16
ZA - Sudafrica 16
UZ - Uzbekistan 15
VE - Venezuela 15
FR - Francia 12
SA - Arabia Saudita 12
PH - Filippine 11
MA - Marocco 10
MY - Malesia 10
RU - Federazione Russa 10
TN - Tunisia 9
CL - Cile 8
AE - Emirati Arabi Uniti 7
CA - Canada 7
DZ - Algeria 6
ES - Italia 6
NL - Olanda 6
PY - Paraguay 6
UA - Ucraina 6
JO - Giordania 5
KE - Kenya 5
PL - Polonia 4
BO - Bolivia 3
CR - Costa Rica 3
EG - Egitto 3
HN - Honduras 3
JM - Giamaica 3
KZ - Kazakistan 3
NG - Nigeria 3
NP - Nepal 3
PA - Panama 3
PE - Perù 3
UY - Uruguay 3
AT - Austria 2
AZ - Azerbaigian 2
CH - Svizzera 2
CM - Camerun 2
CW - ???statistics.table.value.countryCode.CW??? 2
IL - Israele 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
RO - Romania 2
SY - Repubblica araba siriana 2
AL - Albania 1
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
FI - Finlandia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
KG - Kirghizistan 1
ME - Montenegro 1
MK - Macedonia 1
PT - Portogallo 1
QA - Qatar 1
RE - Reunion 1
SN - Senegal 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
YE - Yemen 1
Totale 2.913
Città #
San Jose 581
Singapore 245
Ashburn 184
Hong Kong 163
Beijing 110
Rome 52
Mexico City 47
Ho Chi Minh City 45
Hanoi 27
São Paulo 20
Santa Clara 16
Tashkent 15
Rio de Janeiro 13
Baghdad 12
Lahore 9
Belo Horizonte 8
Brasília 8
Guayaquil 8
Curitiba 7
Joinville 7
Medellín 7
Quito 7
Bogotá 6
Dhaka 6
Kuala Lumpur 6
Orem 6
Riyadh 6
Uberlândia 6
Campinas 5
Frankfurt am Main 5
Haiphong 5
Porto Alegre 5
Atlanta 4
Caracas 4
Feira de Santana 4
Guarulhos 4
Jakarta 4
Jeddah 4
João Pessoa 4
London 4
Mumbai 4
Nairobi 4
Nova Iguaçu 4
Sorocaba 4
Tunis 4
Abuja 3
Amman 3
Aracaju 3
Araraquara 3
Asunción 3
Cape Town 3
Chennai 3
Contagem 3
Da Nang 3
Dubai 3
Fortaleza 3
Goiânia 3
Hải Dương 3
Juazeiro 3
Karbala 3
Lucknow 3
Maceió 3
Montevideo 3
Naples 3
Osasco 3
Panama City 3
Piracicaba 3
Presidente Prudente 3
Santa Maria 3
Santiago 3
Serra 3
São José dos Campos 3
Wroclaw 3
Abu Dhabi 2
Agadir 2
Algiers 2
Almirante Tamandaré 2
Astana 2
Baku 2
Baltimore 2
Basra 2
Bauru 2
Beirut 2
Betim 2
Bexley 2
Bhopal 2
Boa Vista 2
Buenos Aires 2
Bắc Giang 2
Caloocan 2
Camaragibe 2
Can Tho 2
Caruaru 2
Casablanca 2
Chandigarh 2
Chicago 2
Conceição do Mato Dentro 2
Criciúma 2
Dammam 2
Delhi 2
Totale 1.837
Nome #
Comparative analysis of the neutralizing activity against SARS- CoV-2 Wuhan-Hu-1 strain and variants of concern: Performance evaluation of a pseudovirus-based neutralization assay 40
Bcl-2 inhibits the caspase-dependent apoptosis induced by SARS-CoV without affecting virus replication kinetics 40
External quality assessment of SARS-CoV-2 serology in European expert laboratories, April 2021 38
COVID-19 disease-Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study 38
Access and benefit-sharing by the European Virus Archive in response to COVID-19 37
Casi di febbre Chikungunya in Italia in viaggiatori di ritorno dall’Oceano Indiano e rischio di introduzione nel territorio italiano [Cases of Chikungunya fever in Italy in travellers returning from the Indian Ocean and risk of introduction of the disease to Italy] 37
16S rRNA gene sequencing of rectal swab in patients affected by COVID-19 36
First Italian Ebola virus disease case: management of hospital internal and external communication 34
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea 34
Emerging viral infections in immunocompromised patients: A great challenge to better define the role of immune response 34
The World Health Organization Pandemic Agreement draft: Considerations by the ESCMID Emerging Infections Task Force (EITaF) 34
Cat-to-Human Orthopoxvirus Transmission, Northeastern Italy 33
A molecular beacon, bead-based assay for the detection of nucleic acids by flow cytometry 32
Implications of the 2023-2024 MPXV Clade I Outbreak in the DRC to Global Public Health 32
The European network of Biosafety-Level-4 laboratories: enhancing European preparedness for new health threats 32
Compartmentalized Replication of SARS-Cov-2 in Upper vs. Lower Respiratory Tract Assessed by Whole Genome Quasispecies Analysis 31
SARS-CoV-2 Phylogenetic Analysis, Lazio Region, Italy, February-March 2020 31
Geographical Variability Affects CCHFV Detection by RT-PCR: A Tool for In-Silico Evaluation of Molecular Assays 30
Severe acute respiratory syndrome coronavirus 2 escape mutants and protective immunity from natural infections or immunizations 30
Biosafety Level-4 Laboratories in Europe: Opportunities for Public Health, Diagnostics, and Research 30
Rapid, differential diagnosis of orthopox- and herpesviruses based upon real-time PCR product melting temperature and restriction enzyme analysis of amplicons 30
Identification of highly pathogenic microorganisms by matrix-assisted laser desorption ionization-time of flight mass spectrometry: Results of an interlaboratory ring trial 30
Blood kinetics of Ebola virus in survivors and nonsurvivors 29
Virological and Serological Characterisation of SARS-CoV-2 Infections Diagnosed After mRNA BNT162b2 Vaccination Between December 2020 and March 2021 29
Zika virus and microcephaly: is the correlation causal or coincidental? 29
Viral Hemorrhagic Fevers Other than Ebola and Lassa 29
Viral hemorrhagic fevers: advancing the level of treatment 29
Human Zika infection induces a reduction of IFN-gamma producing CD4 T-cells and a parallel expansion of effector V delta 2 T-cells 28
Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa? 28
Pulmonary Involvement during the Ebola Virus Disease 28
Frequency of Detection of Upper Respiratory Tract Viruses in Patients Tested for Pandemic H1N1/09 Viral Infection 28
Virological Characterization of the First 2 COVID-19 Patients Diagnosed in Italy: Phylogenetic Analysis, Virus Shedding Profile From Different Body Sites, andAntibody Response Kinetics 28
A case of dengue type 3 virus infection imported from Africa to Italy, October 2009 28
Different features of V delta 2 T and NK cells in fatal and non-fatal human Ebola infections 28
Evaluation of a rapid and sensitive RT-qPCR assay for the detection of Ebola Virus 28
Full-Length Genome Sequence of a Chikungunya Virus Isolate from the 2017 Autochthonous Outbreak, Lazio Region, Italy 28
Presence of the A226V mutation in autochthonous and imported Italian chikungunya virus strains 28
Circulation of bla_KPC-3-Carrying IncX3 Plasmids among Citrobacter freundii Isolates in an Italian Hospital 28
Alkhurma Hemorrhagic Fever in Travelers Returning from Egypt, 2010 27
Postmortem Findings in Italian Patients with COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities 27
Occupational transmission of an Orthopoxvirus infection during an outbreak in a colony of Macaca tonkeana in Lazio Region, Italy, 2015. 27
EBOLA Ag K-SeT rapid test: field evaluation in Sierra Leone 27
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting 27
Chikungunya Outbreak in the Republic of the Congo, 2019-Epidemiological, Virological and Entomological Findings of a South-North Multidisciplinary Taskforce Investigation 27
Real-time, portable genome sequencing for Ebola surveillance. 27
IgG Against Dengue Virus in Healthy Blood Donors, Zanzibar, Tanzania 27
Molecular analysis of clinical isolates of ceftazidime-avibactam-resistant Klebsiella pneumoniae 26
Clinical, Virologic, and Epidemiologic Characteristics of Dengue Outbreak, Dar es Salaam, Tanzania, 2014 26
COVID-19 Rapid Antigen Test as Screening Strategy at Points of Entry: Experience in Lazio Region, Central Italy, August-October 2020 26
Hospital preparedness and management of patients affected by viral haemorrhagic fever or smallpox at the Lazzaro Spallanzani Institute, Italy. 26
Unique human immune signature of Ebola virus disease in Guinea 26
Seroprevalence of dengue infection: a cross-sectional survey in mainland Tanzania and on Pemba Island, Zanzibar 26
Facing the threat of highly infectious diseases in Europe: the need for a networking approach 25
Epidemiological and Molecular Investigation of the Heater-Cooler Unit (HCU)-Related Outbreak of Invasive Mycobacterium chimaera Infection Occurred in Italy 25
Temporal and spatial analysis of the 2014-2015 Ebola virus outbreak in West Africa 25
Lessons from the COVID-19 Pandemic-Unique Opportunities for Unifying, Revamping and Reshaping Epidemic Preparedness of Europe's Public Health Systems 25
Short-term economic impact of the Zika virus outbreak 25
Hospitalized patients with diarrhea: Rate of Clostridioides difficile infection underdiagnosis and drivers of clinical suspicion. 25
Molecular mechanisms of Ebola virus pathogenesis: focus on cell death 25
Hospital preparedness for knowledge-based response to Ebola and other emerging infectious diseases: A continuous challenge 25
Benefits of a European project on diagnostics of highly pathogenic agents and assessment of potential "dual use" issues. 24
The chronology of the international response to Ebola in Western Africa: lights and shadows in a frame of conflicting position and figures 24
Sampling Surfaces for Ebola Virus Persistence After Cleaning Procedures in High-Level Isolation Settings: The Experience With 2 Patients at the Lazzaro Spallanzani National Institute for Infectious Diseases 24
Detection of Viral RNA in Tissues following Plasma Clearance from an Ebola Virus Infected Patient 24
Molecular Characterization of Autochthonous Chikungunya Cluster in Latium Region, Italy 24
Relationship Between Viremia and Specific Organ Damage in Ebola Patients: A Cohort Study 24
Antagonistic Antiviral Activity between IFN-Lambda and IFN-Alpha against Lethal Crimean-Congo Hemorrhagic Fever Virus In Vitro 24
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 24
Implementation of Whole Genome Sequencing of Tuberculosis Isolates in a Referral Center in Rome: Six Years' Experience in Characterizing Drug-Resistant TB and Disease Transmission 24
The contribution of the European high containment laboratories during the 2014-2015 Ebola Virus Disease emergency 24
Virus genomes reveal factors that spread and sustained the Ebola epidemic 24
Temporary neurocognitive impairment with Ebola virus 24
The Prevalence of Antibodies to Human Herpesvirus 8 and Hepatitis B virus in Patients in Two Hospitals in Tanzania 23
Heterogeneity of West Nile virus genotype 1a in Italy, 2011 23
Molecular Signature of the Ebola Virus Associated with the Fishermen Community Outbreak in Aberdeen, Sierra Leone, in February 2015. 23
Ebola virus infection induces autoimmunity against dsDNA and HSP60 23
Ebolavirus and Marburgvirus: Insight the Filoviridae family 23
Prioritization of High Consequence Viruses to Improve European Laboratory Preparedness for Cross-Border Health Threats. 23
Molecular Characterization of the First Ebola Virus Isolated in Italy, from a Health Care Worker Repatriated from Sierra Leone. 23
Crimean-Congo Hemorrhagic Fever, Southwestern Bulgaria 23
Mandatory immunization against SARS- CoV-2 of athletes, companions and supporters for the Tokyo Olympics 23
Piano per la gestione dell'assistenza sanitaria di casi sospetti o accertati con patologie riconducibili ad agenti biologici utilizzati a fini bioterroristici. Seconda edizione riveduta e aggiornata 23
The Easy-to-Use SARS-CoV-2 Assembler for Genome Sequencing: Development Study. 23
SARS-CoV-2 Early Screening at the Point of Entry: Travelers From Bangladesh to Italy-July 2020 23
Transgenic chloroplasts are efficient sites for high-yield production of the vaccinia virus envelope protein A27L in plant cells 23
Three cases of Zika virus imported in Italy: need for a clinical awareness and evidence-based knowledge 22
Enabling Rapid Response to the 2014-2016 Ebola Epidemic: The Experience and the Results of the National Institute for Infectious Diseases Lazzaro Spallanzani 22
Investigation of Nasal/Oropharyngeal Microbial Community of COVID-19 Patients by 16S rDNA Sequencing 22
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+counts < 200 cells/mm(3) and HIV-RNA > 5 log(10) copies/mL 22
Is the rate of virological failure to cART continuing to decline in recent calendar years? 22
Diagnosis of Zika virus infection in pregnant women travelling to or residing in endemic areas 21
Retrospective screening of solid organ donors in Italy, 2009, reveals unpredicted circulation of West Nile virus 21
Ebola: missed opportunities for Europe-Africa research 21
Design and clinical application of a molecular method for detection and typing of the influenza A/H1N1 pdm virus 21
Measles Cases during Ebola Outbreak, West Africa, 2013-2106 21
Analysis of Diagnostic Findings From the European Mobile Laboratory in Gueckedou, Guinea, March 2014 Through March 2015. 21
Evaluation of the inactivation effect of Triton X-100 on Ebola virus infectivity 21
Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort Study 20
Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection 20
Ebola virus disease complicated with viral interstitial pneumonia: a case report 20
Totale 2.672
Categoria #
all - tutte 11.798
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.798


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20247 0 0 0 0 0 0 0 0 0 0 0 7
2024/2025661 8 0 2 3 10 4 75 128 33 15 203 180
2025/20262.264 111 21 186 170 247 187 249 117 620 346 10 0
Totale 2.932